Have questions about retatrutide?
Text us: +1 (972) 919-0219
Research Use Only
These products are for laboratory research only and not intended for medical use. They are not FDA-approved to diagnose, treat, cure, or prevent any disease. By purchasing, you certify they will be used solely for research and not for human or animal consumption.
Retatrutide is an investigational peptide studied for its interaction with GLP-1, GIP, and glucagon receptors at the cellular level. Research explores its effects on metabolic signaling, insulin sensitivity pathways, and energy regulation mechanisms in vitro.
Certificate of Analysis
Frequently asked questions
Retatrutide is a synthetic investigational peptide developed as a multi-receptor agonist targeting GLP-1, GIP, and glucagon pathways. It is currently being studied for its potential effects on weight management, glucose regulation, and metabolic health in preclinical and clinical research models. By activating multiple incretin and glucagon receptors, Retatrutide demonstrates broad systemic effects that are under investigation for their relevance in metabolic and endocrine research.
The development of Retatrutide builds on decades of research into incretin-based therapies for metabolic disorders. Early studies with GLP-1 receptor agonists established their role in glucose homeostasis and appetite regulation. Subsequent research expanded to dual agonists like tirzepatide (GLP-1/GIP), paving the way for Retatrutide, which uniquely integrates GLP-1, GIP, and glucagon receptor activity. This multi-agonist design reflects a new direction in peptide therapeutics aimed at investigating more comprehensive metabolic modulation in laboratory and clinical settings.
Retatrutide Structure
CAS #: 2381089-83-2
Molecular Formula: C₂₂₁H₃₄₂N₄₆O₆₈
Molecular Weight: 4845.44 g/mol
PubChem ID: 474492335
Retatrutide has been examined in metabolic and systemic models, with studies highlighting its influence on glucose regulation, insulin signaling, lipid metabolism, and integrated hormone pathways. Research also points to its role in energy balance and multi-system signaling in preclinical and laboratory settings.
Key Areas of Research:
• Metabolic: Glucose, insulin, energy regulation
• Endocrine: GLP-1, GIP, glucagon pathways
• Cardiovascular: Lipid, cholesterol, hepatic signaling
• Systemic: Multi-hormone signaling, resilience, balance
Together, these findings suggest broad experimental potential for Retatrutide across metabolic, cardiovascular, and systemic models. By engaging multiple hormone pathways, it provides a versatile research platform for studying energy regulation, lipid metabolism, and integrated signaling across diverse biological systems.
Jastreboff A.M. et al., New England Journal of Medicine, 2023
